Patent Applications published on Nov 21, 2024 - page 3

#601
US20240382401A1
Human necessities

COMPOSITIONS

#602
US20240382402A1
Human necessities

COMPOSITION FOR PREVENTING OR REDUCING MICROBES ON A SURFACE

#603
US20240382403A1
Human necessities

COSMETIC, DERMATOLOGICAL OR COSMECEUTICAL TREATMENT, IN PARTICULAR PROPIGMENTING

#604
US20240382404A1
Human necessities

SKIN CARE SERUM COMPOSITION WITH NATURAL POLYMERS

#605
US20240382405A1
Human necessities

POLYESTER ELASTOMERS FROM DI-CARBOXYLIC ACID OR TRI-CARBOXYLIC ACID, MONOCARBOXYLIC ACID, AND POLYOL FOR COSMETIC AND PERSONAL CARE APPLICATIONS

#606
US20240382406A1
Human necessities

PROCESS FOR TREATING KERATINOUS MATERIAL, COMPRISING THE MIXING OF AT LEAST TWO AGENTS (A) AND (B)

#607
US20240382407A1
Human necessities

PROCESS FOR TREATING KERATINOUS MATERIAL, COMPRISING THE MIXING OF AT LEAST TWO AGENTS (A) AND (B)

#608
US20240382408A1
Human necessities

COSMETIC COMPOSITION FOR USE ON THE SKIN

#609
US20240382409A1
Human necessities

COMPOSITION FOR ANTI-AGING AND SKIN IMPROVEMENT, COMPRISING COMPLEX OF INDIAN GOOSE-BERRY EXTRACT AND BARLEY SPROUT EXTRACT (lB COMPLEX) AS ACTIVE INGREDIENT

#610
US20240382410A1
Human necessities

ROBOTIC MICROCAPSULE ASSEMBLIES WITH EMERGENT MOBILITY FOR TARGETED TREATMENT AND DRUG DELIVERY

#611
US20240382411A1
Human necessities

COMPOSITION COMPRISING PD-L1 ANTIGEN-BINDING FRAGMENT AND USE THEREOF

#612
US20240382412A1
Human necessities

BIOORTHOGONAL CATALYTIC PATCH AND METHODS OF USING THE SAME

#613
US20240382413A1
Human necessities

Polymeric Microstructures and Systems and Methods for Making Same

#614
US20240382414A1
Human necessities

LIPID EMULSION FOR PARENTERAL NUTRITION COMPRISING GPC

#615
US20240382415A1
Human necessities

NASAL HYGIENE COMPOSITIONS, ANTIMICROBIAL TREATMENTS, DEVICES, AND ARTICLES FOR DELIVERY OF SAME TO THE NOSE, TRACHEA AND MAIN BRONCHI

#616
US20240382416A1
Human necessities

METHOD OF TREATING INFLAMMATION AND PHOTORECEPTOR CELL DEGENERATION IN RETINAL DEGENERATION PATIENTS

#617
US20240382417A1
Human necessities

Compositions Comprising Guaifenesin and Eriodictyol

#618
US20240382418A1
Human necessities

GASTRIC RESIDENCE SYSTEMS WITH RELEASE RATE-MODULATING FILMS

#619
US20240382419A1
Human necessities

METERED DOSE INHALERS AND SOLUTION COMPOSITIONS

#620 ✅ Patent 12,263,245 granted on 2025-04-01
US20240382420A1
Human necessities

Immunomodulating treatments of body cavities

#621
US20240382421A1
Human necessities

WATER SOLUBLE COMPOSITIONS AND METHODS OF MAKING THE SAME

#622
US20240382422A1
Human necessities

POLYMERIC MICELLE NANOPARTICLES FOR ON-DEMAND CELLULAR PACKAGING OF EXTRACELLULAR VESICLES

#623
US20240382423A1
Human necessities

EXTERNAL NANO LINIMENT FOR GOUT AND PREPARATION METHOD THEREOF

#624
US20240382424A1
Human necessities

LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF

#625
US20240382425A1
Human necessities

RNA binding and stabilising cationic liposome, its application and method of loading the liposome with emetine

#626
US20240382426A1
Human necessities

ORALLY DISINTEGRATING DOSAGE FORM FOR ADMINISTRATION OF AVANAFIL, AND ASSOCIATED METHODS OF MANUFACTURE AND USE

#627
US20240382427A1
Human necessities

NOVEL GASTRORETENTIVE EXTENDED RELEASE DOSAGE FORM

#628
US20240382428A1
Human necessities

PROCESS FOR THE MANUFACTURE OF A SOLID PHARMACEUTICAL ADMINISTRATION FORM

#629
US20240382429A1
Human necessities

POLYMERIC NANOPARTICLE GENETIC VACCINES

#630
US20240382430A1
Human necessities

DNAZYME HYDROGEL FORMULATIONS

#631
US20240382431A1
Human necessities

Enteric-Coated Particles Containing Lactoferrin

#632
US20240382432A1
Human necessities

SINGLE CHAIN VARIABLE FRAGMENT (SCFV) MODIFIED LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF

#633
US20240382433A1
Human necessities

DISSOLVABLE GEL-FORMING FILM FOR DELIVERY OF ACTIVE AGENTS

#634
US20240382434A1
Human necessities

CARYOPHYLLENE-CONTAINING COMPOSITION

#635
US20240382435A1
Human necessities

NON-CERULOPLASMIN BOUND COPPER LEVEL MONITORING

#636
US20240382436A1
Human necessities

APPLICATION OF R-KETAMINE AND SALT THEREOF AS PHARMACEUTICALS

#637
US20240382437A1
Human necessities

TREATMENT OF ACUTE TISSUE INJURY

#638
US20240382438A1
Human necessities

Calcium Channel Blockers and Methods Thereof

#639
US20240382439A1
Human necessities

NON-SURGICAL LASER TREATMENT FOR A FIBROUS MASS

#640
US20240382440A1
Human necessities

COMPOSITIONS OF POLYLYSINE CONJUGATES AND OF MICELLES AND/OR COPOLYMERS OF POLYLYSINE

#641
US20240382441A1
Human necessities

LEVOTHYROXINE LIQUID FORMULATIONS

#642 ✅ Patent 12,239,623 granted on 2025-03-04
US20240382442A1
Human necessities

Sleep-improving compositions and methods of use

#643
US20240382443A1
Human necessities

GENERATION OF S-NITROSOACETYLCYSTEINE

#644
US20240382444A1
Human necessities

COMPOSITIONS AND USE THEREOF FOR RE-ESTABLISHING INTESTINAL PERMEABILITY AND/OR PREVENTING OR COMBATTING MULTIFACTORIAL DISEASES

#645
US20240382445A1
Human necessities

METHODS OF ADJUVANT THERAPY

#646
US20240382446A1
Human necessities

METHOD FOR IMPROVING FEED INTAKE

#647
US20240382447A1
Human necessities

BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM

#648
US20240382448A1
Human necessities

METHODS FOR TREATING CORONAVIRUS INFECTION

#649
US20240382449A1
Human necessities

RESINIFERATOXIN COMPOSITIONS

#650
US20240382450A1
Human necessities

COMPOSITION OF B-CARYOPHYLLENE AND A STATIN, AND METHODS OF USING SAME

#651
US20240382451A1
Human necessities

ORGANONITRO AND SULFOXYALKYL ORGANONITRO COMPOUNDS FOR USE IN TREATING MEDICAL DISORDERS

#652
US20240382452A1
Human necessities

COMPOSITIONS AND DOSAGE FORMS FOR TOPICAL AND TRANSDERMAL DELIVERY OF ACTIVES AND METHODS OF USE

#653
US20240382453A1
Human necessities

PROTEIN HYDROLYSATES

#654
US20240382454A1
Human necessities

ANTIPARASITIC ISOXAZOLINE COMPOUNDS, LONG-ACTING INJECTABLE FORMULATIONS COMPRISING THEM, METHODS AND USES THEREOF

#655
US20240382455A1
Human necessities

COMPOSITION CONTAINING 1H-PYRAZOLE-3-AMIDE-BASED COMPOUND DERIVATIVE FOR PREVENTION OR TREATMENT OF FIBROSIS

#656
US20240382456A1
Human necessities

SYNERGISTIC COMBINATION THERAPY FOR TREATING ALS

#657
US20240382457A1
Human necessities

BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS

#658
US20240382458A1
Human necessities

METHOD FOR DETECTING BACTERIA OF GENUS FUSOBACTERIUM IN ORDER TO DIAGNOSE ENDOMETRIOSIS

#659
US20240382459A1
Human necessities

MECHANISMS OF ANDROGEN RECEPTOR-CENTERED TRANSCRIPTIONAL NETWORKS IN REGULATING CD8+ T CELL EXHAUSTION AND THERAPEUTIC APPLICATIONS IN CANCER

#660
US20240382460A1
Human necessities

Compositions and Methods for Preventing or Improving Premature Skin Aging

#661
US20240382461A1
Human necessities

PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS

#662
US20240382462A1
Human necessities

PRESBYOPIA TREATMENTS

#663
US20240382463A1
Human necessities

Composition Comprising HDAC Inhibitor and Immune Checkpoin Inhibitor and Methods For Using the Same

#664
US20240382464A1
Human necessities

Manufacturing Process for Metaxalone Tablets

#665
US20240382465A1
Human necessities

AROMATIC ACETYLENE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#666
US20240382466A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER’S DISEASE

#667
US20240382467A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING LUNG INJURY

#668
US20240382468A2
Human necessities

TETRAZOLE DERIVATIVES

#669
US20240382469A1
Human necessities

COMBINATION THERAPY WITH DEUTERATED IMIDAZOQUINOLINES

#670
US20240382470A1
Human necessities

Irak Inhibitor for Treating Cytokine Release-Related Conditions Associated With Infection by a Respiratory Virus

#671
US20240382471A1
Human necessities

GLUCAGON-LIKE PEPTIDE-1 RECEPTOR MODULATORS AND USES THEREOF

#672
US20240382472A1
Human necessities

NEUTROPHIL ELASTASE INHIBITORS FOR USE IN THE TREATMENT OF FIBROSIS

#673
US20240382473A1
Human necessities

Combination Therapies for Treatment of Myelodysplastic Syndrome

#674
US20240382474A1
Human necessities

ENPP1 MODULATORS AND USES THEREOF

#675
US20240382475A1
Human necessities

Quinazoline Derivative, Or Preparation Method Therefor And Use Thereof

#676
US20240382476A1
Human necessities

ANDROGEN RECEPTOR BIOMARKERS FOR CANCER THERAPY

#677
US20240382477A1
Human necessities

NITROGEN-CONTAINING HETEROCYCLIC PYRIDINE COMPOUND

#678
US20240382478A1
Human necessities

PIMOBENDAN FORMULATION AND METHOD OF USE THEREOF

#679 ✅ Patent 12,144,810 granted on 2024-11-19
US20240382479A1
Human necessities

IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE

#680
US20240382480A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING JAK3/JAK1/TBK1 SELECTIVE INHIBITOR AND MEDICAL USE THEREOF

#681
US20240382481A1
Human necessities

SRPK INHIBITORS

#682
US20240382482A1
Human necessities

PLASMA KALLIKREIN INHIBITORS

#683
US20240382483A1
Human necessities

HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

#684
US20240382484A1
Human necessities

COMPOSITION FOR TREATING, PREVENTING, OR AMELIORATING MELANOMA AND METHOD THEREOF

#685
US20240382485A1
Human necessities

METHODS OF TREATING ABNORMAL CELL GROWTH

#686
US20240382486A1
Human necessities

PYRIMIDINEDIONE COMPOUNDS

#687
US20240382487A1
Human necessities

NOVEL COPI/ARF1-LIPOLYSIS PATHWAY INHIBITOR AND COMPOUND FOR ERADICATING CANCER STEM CELLS AND INDUCING DAMP-MEDIATED ANTI-TUMOR IMMUNE RESPONSE

#688
US20240382488A1
Human necessities

NEK7 INHIBITORS

#689
US20240382489A1
Human necessities

LIQUID PHARMACEUTICAL COMPOSITION

#690
US20240382490A1
Human necessities

QUINAZOLINE-THIOHYDANTOIN FUSED HETEROCYCLES WHICH ARE SUITABLE FOR TREATING, AMELIORATING OR PREVENTING A PROLIFERATIVE DISORDER

#691
US20240382491A1
Human necessities

METHODS FOR TREATING NEUROGENERATIVE DISEASES

#692
US20240382492A1
Human necessities

THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF ANTI-CANCER AGENT(S) AND IMMUNE CHECKPOINT INHIBITOR(S)

#693
US20240382493A1
Human necessities

METHODS FOR TREATING SYSTEMIC MASTOCYTOSIS AND GASTROINTESTINAL STROMAL TUMORS

#694
US20240382494A1
Human necessities

THERAPEUTIC COMPOUNDS

#695
US20240382495A1
Human necessities

COMBINATIONS OF COPANLISIB WITH ANTI-PD-1 ANTIBODY

#696
US20240382496A1
Human necessities

TREATMENT OF SKIN LESIONS

#697
US20240382497A1
Human necessities

PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPOXIC INJURY, ISCHAEMIA-REPERFUSION INJURY AND INFLAMMATION, CELL PROTECTION AGENT FOR TRANSPLANTATION, AND BIO-PRESERVATION AGENT

#698
US20240382498A1
Human necessities

NOVEL INHIBITOR OF HYPE-MEDIATED AMPYLATION

#699
US20240382499A1
Human necessities

INDUCERS OF SENESCENCE, IN COMBINATION WITH A SELECTIVE DEATH RECEPTOR 5 (DR5) AGONIST, FOR USE IN A METHOD OF TREATING CANCER

#700
US20240382500A1
Human necessities

DOPAMINE RECEPTOR AGONISTS OR ANGIOTENSIN RECEPTOR BLOCKERS OR COMBINATIONS THEREOF FOR COVID-19 SEQUELAE

#701
US20240382501A1
Human necessities

COMBINATION THERAPY FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

#702
US20240382502A1
Human necessities

COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY

#703
US20240382503A1
Human necessities

CANNABINOID, DRUG ADDICTION TREATMENT AND MENTHOL COMPOSITIONS AND METHODS

#704
US20240382504A1
Human necessities

TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS

#705
US20240382505A1
Human necessities

FOOD PRODUCT

#706
US20240382506A1
Human necessities

Means and Methods to Regulate Gut Dysbiosis

#707
US20240382507A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,4,5- TETRAHYDROBENZOTHIEPIN- 1,1-DIOXIDE DERIVATIVES AND THE USE THEREOF

#708
US20240382508A1
Human necessities

REGENERATIVE AGENT FOR BONE TISSUE AND LUNG TISSUE, AND PHARMACEUTICAL COMPOSITION FOR REGENERATING BONE TISSUE AND LUNG TISSUE

#709
US20240382509A1
Human necessities

Cannabinoids C- and O-glycosides possessing anti-proliferative and anti-metastatic properties and process for preparation thereof

#710
US20240382510A1
Human necessities

NEW COMBINATION DRUG FOR TREATING CORONAVIRUS INFECTIONS, PHARMACEUTICAL COMPOSITION AND USE THEREOF

#711
US20240382511A1
Human necessities

NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION

#712
US20240382512A1
Human necessities

Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof

#713
US20240382513A1
Human necessities

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF GENES ASSOCIATED WITH MUSCLE HEALTH

#714
US20240382514A1
Human necessities

NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING SAME, AND PREPARATION METHOD AND USE THEREOF

#715
US20240382515A1
Human necessities

WATER-SOLUBLE DIETARY FIBER, USE THEREOF IN PREPARATION OF MEDICAMENT THAT PROMOTES METABOLISM OF ELLAGIC ACID INTO UROLITHIN A, AND PHARMACEUTICAL COMPOSITION

#716
US20240382516A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR INCREASING MITOCHONDRIAL ACTIVITY AND/OR IMPROVING ADIPONECTIN PRODUCTION

#717
US20240382517A1
Human necessities

Topical Pharmaceutical Skin Composition for the Delivery of Nitric Oxide in Combination with Other Topical Dermatologic Agents

#718
US20240382518A1
Human necessities

PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR PREVENTION OR TREATMENT OF OSTEOARTHRITIS

#719
US20240382519A1
Human necessities

MONOVALENT COPPER/PORPHYRIDIUM SP. POLYSACCHARIDE COMPLEXES, RELATED PRODUCTS AND METHODS OF PREPARATION THEREOF

#720
US20240382520A1
Human necessities

COMPOSITION FOR PREVENTING AND TREATING CANCER THROUGH MITOCHONDRIAL METABOLISM REGULATION CONTAINING NANOGRAPHENE STRUCTURE

#721
US20240382521A1
Human necessities

METHODS OF ENGINEERING IMMUNE CELLS HAVING REDUCED FRATRICIDAL ACTIVITY

#722 ✅ Patent 12,351,640 granted on 2025-07-08
US20240382522A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR AND CAR-T CELLS THAT BIND BCMA

#723
US20240382523A1
Human necessities

OFF-THE-SHELF IPSC-DERIVED CAR-NK CELL AS MONOTHERAPY AND IN COMBINATION WITH ANTIBODY

#724
US20240382524A1
Human necessities

TREATING MULTIPLE MYELOMA

#725
US20240382525A1
Human necessities

CD4+ AND/OR CD8+ CELL POPULATIONS COMPRISING ICARS FOR USE IN TREATMENT THERAPIES

#726
US20240382526A1
Human necessities

NUCLEIC ACIDS ENCODING ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

#727
US20240382527A1
Human necessities

METHODS OF TREATING OVARIAN CONDITIONS AND DISEASES

#728
US20240382528A1
Human necessities

TREATMENT OF POLYCYTHEMIA VERA VIA CRISPR/AAV6 GENOME EDITING

#729
US20240382529A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SPINAL CORD INJURIES

#730
US20240382530A1
Human necessities

DEVICE FOR PREPARING LIPOSUCTION FAT FOR AUTOLOGOUS FAT TRANSFER

#731
US20240382531A1
Human necessities

CELL POPULATIONS AND GENE EXPRESSION ASSOCIATED WITH IN VITRO BETA CELL DIFFERENTIATION

#732
US20240382532A1
Human necessities

STEM CELL DERIVED PANCREATIC ISLET DIFFERENTIATION

#733
US20240382533A1
Human necessities

USE OF HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL-DERIVED SMALL EXTRACELLULAR VESICLE (hucMSC-sEV) IN PREPARATION OF DRUG FOR TREATING TYPE 2 DIABETES MELLITUS (T2DM)

#734
US20240382534A1
Human necessities

MITOCHONDRIAL AUGMENTATION THERAPY FOR MYELODYSPLASTIC SYNDROME

#735
US20240382535A1
Human necessities

Use of Sustainable, Modified and Enhanced Aquaculture Limulus Amebocyte Lysate Protein and Hemolymph Compounds as a Biologic Broad Spectrum Antimicrobial Therapy.

#736
US20240382536A1
Human necessities

BACTERIA ENGINEERED TO TREAT A DISEASE OR DISORDER

#737
US20240382537A1
Human necessities

Genetically Modified Mycoplasma Bacteria Active Against Heterogenous Bacterial Biofilms

#738
US20240382538A1
Human necessities

AGENT FOR PREVENTION AND/OR TREATMENT OF PORPHYROMONAS GINGIVALIS INFECTION

#739
US20240382539A1
Human necessities

USE OF INTESTINAL PROBIOTIC IN PREPARATION OF MEDICAMENT THAT PROMOTES METABOLISM OF ELLAGIC ACID INTO UROLITHIN A, PHARMACEUTICAL COMPOSITION AND USE THEREOF

#740
US20240382540A1
Human necessities

MODULATION OF FUSOBACTERIUM VARIUM TO PREVENT BOVINE LIVER ABSCESSES AND IMPROVE CATTLE PERFORMANCE

#741
US20240382541A1
Human necessities

FORMULATIONS TO STABILIZE VIRUS-BASED THERAPEUTICS

#742
US20240382542A1
Human necessities

FORMULATIONS TO STABILIZE VIRUS-BASED THERAPEUTICS

#743
US20240382543A1
Human necessities

PERILESIONAL TREATMENT OF SKIN CONDITIONS

#744
US20240382544A1
Human necessities

COMPOSITION FOR ANTI-OBESITY AND PREVENTING OR TREATING MUSCLE LOSS, CONTAINING CATECHIN GLYCOSIDE EXTRACT DERIVED FROM PLANT IN GENUS ULMUS AS ACTIVE INGREDIENT

#745
US20240382545A1
Human necessities

COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING RESPIRATORY DISEASE COMPRISING FERMENTED CENTELLA ASIATICA EXTRACT AS EFFECTIVE COMPONENT

#746 ✅ Patent 12,161,684 granted on 2024-12-10
US20240382546A1
Human necessities

Method of preparing fermented herbal eye drops

#747
US20240382547A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR CONDITIONING DAMPNESS-HEAT

#748
US20240382548A1
Human necessities

COMPOSITIONS COMPRISING CASTANEA SATIVA EXTRACTS FOR TREATMENT OF HELICOBACTER PYLORI INFECTIONS

#749
US20240382549A1
Human necessities

USE OF MULBERRY EXTRACT FOR IMPROVING SLEEP QUALITY AND/OR SUBSEQUENT BEHAVIOURAL OUTCOMES

#750
US20240382550A1
Human necessities

AQUEOUS SOLUTION BASED ON SYZYGIUM AROMATICUM, AND ASSOCIATED PREPARATION METHOD AND USES

#751 ✅ Patent 12,251,414 granted on 2025-03-18
US20240382551A1
Human necessities

Pharmaceutical composition for treating or improving edema and blood stasis after open surgery

#752
US20240382552A1
Human necessities

COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT

#753
US20240382553A1
Human necessities

COMPOSITIONS USEFUL FOR IMPROVING THE APPEARANCE OF SKIN AND METHODS OF USE THEREOF

#754
US20240382554A1
Human necessities

METHODS OF PREPARING HIGH GINGEROL GINGER EXTRACTS

#755
US20240382555A1
Human necessities

PEPTIDES WITH ANTI-ANGIOGENIC ACTIVITY

#756
US20240382556A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOL DEPENDENCE

#757
US20240382557A1
Human necessities

INHIBITION OF TUMOR NECROSIS FACTOR, PRO-INFLAMMATORY CYTOKINES AND OTHER INFLAMMATORY RESPONSE MEDIATORS

#758
US20240382558A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

#759
US20240382559A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING KAI1 POLYPEPTIDE FOR INHIBITION OF HEPATIC FIBROSIS AND USE THEREOF

#760
US20240382560A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CANCER AND ENHANCING IMMUNE CHECKPOINT INHIBITOR EFFICACY

#761
US20240382561A1
Human necessities

GLUCOREGULATORY COMPOUND, COMPOSITION AND USES THEREOF

#762
US20240382562A1
Human necessities

METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS

#763
US20240382563A1
Human necessities

PROMOTING IMMUNE SURVEILLANCE AGAINST CANCER CELLS

#764
US20240382564A1
Human necessities

Methods and Compositions for Treating Muscular Dystrophy and Memory Impairment

#765
US20240382565A1
Human necessities

SUBLINGUAL SEMAGLUTIDE-BPC 157 COMBINATION FOR WEIGHT LOSS

#766
US20240382566A1
Human necessities

A GLUCOSE-SENSITIVE INSULIN-LOADED MICROPARTICLE

#767
US20240382567A1
Human necessities

Long-acting PTH compound treatments

#768
US20240382568A1
Human necessities

ALKALINE PHOSPHATASE POLYPEPTIDES AND METHODS OF USE THEREOF

#769
US20240382569A1
Human necessities

FUNGAL ENZYME MIXTURES AND USES THEREOF

#770
US20240382570A1
Human necessities

STABLE THERMOLYSIN HYDROGEL

#771
US20240382571A1
Human necessities

Albumin-Free Botulinum Toxin Formulations

#772
US20240382572A1
Human necessities

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

#773
US20240382573A1
Human necessities

COMPOSITIONS INCORPORATING A GENETICALLY ATTENUATED PLASMODIUM WITH MODIFIED LIVER STAGE NUCLEAR PROTEIN (LINUP) AND RELATED METHODS

#774
US20240382574A1
Human necessities

METHODS AND COMPOSITIONS FOR ORALLY DOSING ANIMALS

#775
US20240382575A1
Human necessities

COMPOSITIONS FOR USE AS A PROPHYLACTIC AGENT TO THOSE AT RISK OF INFECTION OF TUBERCULOSIS, OR AS SECONDARY AGENTS FOR TREATING INFECTED TUBERCULOSIS PATIENTS

#776
US20240382576A1
Human necessities

COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF

#777
US20240382577A1
Human necessities

METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS

#778 ✅ Patent 12,233,122 granted on 2025-02-25
US20240382578A1
Human necessities

Methods for treating, ameliorating or preventing infections using drug and vaccination combination treatment

#779
US20240382579A1
Human necessities

METHOD OF PRODUCING A FOOT AND MOUTH DISEASE VIRUS VIRUS-LIKE PARTICLE

#780
US20240382580A1
Human necessities

MULTIVALENT VIRAL PARTICLES

#781
US20240382581A1
Human necessities

PAN-HUMAN CORONAVIRUS VACCINES

#782
US20240382582A1
Human necessities

Immunomodulatory proteins- or targeting proteins-expressing nanovesicles, methods of preparing the nanovesicle and use thereof

#783
US20240382583A1
Human necessities

HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS

#784
US20240382584A1
Human necessities

HBV VACCINE INDUCING PRES-SPECIFIC NEUTRALIZING ANTIBODIES

#785
US20240382585A1
Human necessities

Glyconjugate Vaccines

#786
US20240382586A1
Human necessities

ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF IN THE MEDICAL FIELD

#787
US20240382587A1
Human necessities

CELLULAR THERAPY TO SUPPRESS IMMUNE RESPONSE

#788
US20240382588A1
Human necessities

METHODS OF TREATMENT

#789
US20240382589A1
Human necessities

Synergistic Inhibition of eIF5A and Notch Signaling in Intermediate Tregs

#790
US20240382590A1
Human necessities

NOVEL TUMOR-SPECIFIC ANTIGENS FOR CANCER STEM CELLS AND USES THEREOF

#791
US20240382591A1
Human necessities

METHODS AND COMPOSITION USING PATIENT-DERIVED AUTOLOGOUS NEOANTIGENS FOR TREATING CANCER

#792
US20240382592A1
Human necessities

METHODS FOR THE TREATMENT OF ANAPLASTIC LARGE CELL LYMPHOMA

#793
US20240382593A1
Human necessities

ANTIBODY LOADED IMMUNE CELLS AND METHODS FOR USE IN CANCER TREATMENT

#794 ✅ Patent 12,370,259 granted on 2025-07-29
US20240382594A1
Human necessities

MAGNETIC PARTICLE CONTROL AND VISUALIZATION

#795
US20240382595A1
Human necessities

SYSTEM FOR INDUCING SONOPORATION OF A DRUG INTO CANCER CELLS AND METHOD THEREOF

#796
US20240382596A1
Human necessities

COMPOSITION OF VANCOMYCIN AQUEOUS SOLUTION

#797
US20240382597A1
Human necessities

FORMULATIONS OF ANTI-INFLAMMATORY AGENTS COMPRISING MSM WITH ENHANCED SOLUBILITY IN WATER

#798
US20240382598A1
Human necessities

LIPID FORMULATIONS FOR THE PREPARATION OF HEALTH INGREDIENT-CONTAINING HOT DRINKS

#799
US20240382599A1
Human necessities

EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE

#800
US20240382600A1
Human necessities

BIFUNCTIONAL DEGRADERS COMPRISING A TEAD BINDER

#801
US20240382601A1
Human necessities

EMULSION FORMULATION HAVING HIGH FORMULATION STABILITY AND MANUFACTURING METHOD THEREOF

#802
US20240382602A1
Human necessities

A CIS-PLATINUM(II)-OLIGOMER HYBRID

#803
US20240382603A1
Human necessities

BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR

#804 ✅ Patent 12,220,461 granted on 2025-02-11
US20240382604A1
Human necessities

Polypeptide-coupled small molecule compound and antiviral application thereof

#805
US20240382605A1
Human necessities

CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF

#806
US20240382606A1
Human necessities

NANOPARTICLES FOR ANTIGEN-SPECIFIC CELL PROGRAMMING AND USES THEREOF

#807
US20240382607A1
Human necessities

DRUG CONJUGATE OF ERIBULIN DERIVATIVE

#808
US20240382608A1
Human necessities

NOVEL LIGAND-DRUG CONJUGATE OF CAMPTOTHECIN ANALOGS, INTERMEDIATES, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

#809
US20240382609A1
Human necessities

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

#810
US20240382610A1
Human necessities

NECTIN-4 ANTIBODIES AND CONJUGATES

#811
US20240382611A1
Human necessities

PEPTIDE-CONTAINING LINKERS FOR ANTIBODY-DRUG CONJUGATES

#812
US20240382612A1
Human necessities

BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF

#813
US20240382613A1
Human necessities

METHODS AND SYSTEMS FOR ULTRASOUND STIMULATED STRUCTURES AND DELIVERY OF THERAPEUTIC SPECIES

#814
US20240382614A1
Human necessities

Self-Assembling Nanoparticles Based On Amphiphilic Peptides for Drug Delivery Applications

#815
US20240382615A1
Human necessities

MICELLE COMPLEX AND DRUG CARRIER COMPRISING SAME

#816 ✅ Patent 12,171,842 granted on 2024-12-24
US20240382616A1
Human necessities

Method for hyperthermially treating a cancer

#817
US20240382617A1
Human necessities

VIRUS COMPOSITIONS TO EFFICIENTLY TARGET THE NERVOUS SYSTEM AND THE LUNGS

#818
US20240382618A1
Human necessities

Treatment of nerve damage using 5'UTR of Gpr151 gene or variant thereof

#819
US20240382619A1
Human necessities

PLASMID PLATFORM FOR STABLE EXPRESSION AND DELIVERY OF BIOMOLECULES

#820
US20240382620A1
Human necessities

GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 3

#821
US20240382621A1
Human necessities

COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION

#822
US20240382622A1
Human necessities

COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION

#823
US20240382623A1
Human necessities

SYSTEMS AND METHODS FOR THE TARGETED PRODUCTION OF A THERAPEUTIC PROTEIN WITHIN A TARGET CELL

#824
US20240382624A1
Human necessities

FIBROBLAST ACTIVATION PROTEIN TARGETED DYES THEIR RELATED USES

#825
US20240382625A1
Human necessities

INDICATOR COMPOUNDS, DEVICES COMPRISING INDICATOR COMPOUNDS, AND METHODS OF MAKING AND USING THE SAME

#826
US20240382626A1
Human necessities

IRRADIATION AMENABLE LIPOSOMAL DYE AGGREGATES AND METHODS OF SYNTHESIS AND USE THEREOF

#827
US20240382627A1
Human necessities

NON-METALLIC TEMPERATURE-RESPONSIVE COMPOSITE FOR MAGNETIC RESONANCE IMAGING (MRI), AND PREPARATION METHOD AND USE THEREOF

#828
US20240382628A1
Human necessities

COMPOSITIONS AND METHODS RELATING TO CELLS WITH ADHERED PARTICLES

#829
US20240382629A1
Human necessities

HETEROBIVALENT AND HOMOBIVALENT AGENTS TARGETING FIBROBLAST ACTIVATION PROTEIN ALPHA AND/OR PROSTATE-SPECIFIC MEMBRANE ANTIGEN

#830 ✅ Patent 12,214,059 granted on 2025-02-04
US20240382630A1
Human necessities

Cleavable radioligands for targeting cell surface receptors and uses thereof

#831
US20240382631A1
Human necessities

USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER

#832
US20240382632A1
Human necessities

METHODS OF PREPARATION OF 18F LABELLED SILYL-FLUORIDE COMPOUNDS

#833
US20240382633A1
Human necessities

RADIOPHARMACEUTICALS, METHODS FOR THE PRODUCTION THEREOF, AND USES IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES

#834
US20240382634A1
Human necessities

Flexible Diffuse-Reflective Smart Chamber for Effective Target Dosing of Complex Plant Surfaces and Methods of Use Thereof

#835
US20240382635A1
Human necessities

PLASMA TREATMENT DEVICE AND METHOD OF TREATING A SURFACE

#836
US20240382636A1
Human necessities

ADAPTIVE FOOTWEAR SANITIZATION DEVICE

#837
US20240382637A1
Human necessities

WRITING UTENSIL SANITIZING ASSEMBLY AND METHOD

#838
US20240382638A1
Human necessities

APPARATUS AND A METHOD FOR EJECTING ONE OR MORE SUBSTANCES

#839
US20240382639A1
Human necessities

Chemical Formulations and Their Use in Neutralizing or Eliminating Odors

#840
US20240382640A1
Human necessities

Fragrance Delivery System

#841
US20240382641A1
Human necessities

WEARABLE ELECTRONIC DEVICE FOR PROVIDING OR AFFECTING SMELL

#842
US20240382642A1
Human necessities

ELECTRONIC FRAGRANCE DIFFUSER SYSTEM AND METHOD

#843
US20240382643A1
Human necessities

AROMA DEVICE APPLICATIONS

#844
US20240382644A1
Human necessities

DISINFECTING AND VIRUS INACTIVATING DEVICE, AIR-CONDITIONING APPARATUS INCLUDING DISINFECTING AND VIRUS INACTIVATING DEVICE THEREON, AND DISINFECTION AND VIRUS INACTIVATION METHOD

#845
US20240382645A1
Human necessities

PACKAGING SOLUTIONS

#846
US20240382646A1
Human necessities

WOUND DRESSING APPARATUSES AND METHODS FOR NITRIC OXIDE DELIVERY

#847
US20240382647A1
Human necessities

Method for Preparing an Intramammary Teat Sealing Composition and Sealing Composition Obtained By Such Process

#848
US20240382648A1
Human necessities

POLYACRYLAMIDE HYDROGEL FOR USE IN THE TREATMENT AND/OR PREVENTION OF OSTEOARTHRITIS

#849
US20240382649A1
Human necessities

BIOCOMPATIBLE POLYMER, BIOCOMPATIBLE COMPOSITIONS, SOL OR GEL, AND INJECTABLE COMPOSITION

#850
US20240382650A1
Human necessities

COMPOSITION COMPRISING A CROSS-LINKED POLYOL

#851
US20240382651A1
Human necessities

BUPIVACAINE-COLLAGEN DRUG DELIVERY IMPLANT AND METHODS OF MAKING AND USING THEREOF

#852
US20240382652A1
Human necessities

OPTIMIZED SOLID SUBSTRATES, TOOLS FOR USE WITH SAME AND USES THEREOF FOR PROMOTING CELL AND TISSUE GROWTH

#853
US20240382653A1
Human necessities

MODIFIED SIS MEMBRANE FOR TISSUE REPAIR, PREPARATION METHOD THEREFOR AND USE THEREOF

#854
US20240382654A1
Human necessities

CHEMICAL CROSS-LINKING BASED POROUS MATERIAL FOR TISSUE REGENERATION AND HEMOSTASIS COMPRISING EXTRACELLULAR MATRIX OF DECELLULARIZED KIDNEY TISSUE AND PREPARATION METHOD THEREOF

#855
US20240382655A1
Human necessities

NITRIC OXIDE AND CHLORHEXIDINE RELEASING CATHETER FOR ANTI-PLATELET AND ANTIMICROBIAL DUAL FUNCTIONALITY

#856
US20240382656A1
Human necessities

Drug Coatings for Medical Devices

#857
US20240382657A1
Human necessities

SYSTEM AND METHOD FOR SYRINGE PUMP BLOOD TRANSFUSION

#858
US20240382658A1
Human necessities

SYSTEM FOR ASEPTIC COLLECTION AND ENTERAL DELIVERY

#859
US20240382659A1
Human necessities

EVALUATING INTEGRITY OF A FORWARD OSMOSIS MEMBRANE DURING CONTINUOUS FLOW

#860
US20240382660A1
Human necessities

AUTOMATED PERITONEAL DIALYSIS CYCLER HAVING GRAVIMETRIC CONTROL

#861
US20240382661A1
Human necessities

ISOLATION AND TREATMENT OF AN ORGAN OR TUMOR

#862
US20240382662A1
Human necessities

MEDICAL DEVICE DISLODGMENT DETECTION

#863
US20240382663A1
Human necessities

HLM PUMP STOP REACTION

#864
US20240382664A1
Human necessities

PHACOEMULSIFICATION VACUUM SURGE DETECTION WITH CORRELATED VACUUM AND PRESSURE READINGS

#865
US20240382665A1
Human necessities

ANTI-BACKFLOW NASAL ASPIRATOR

#866
US20240382666A1
Human necessities

FLUID STORAGE CANISTER

#867
US20240382667A1
Human necessities

Device And Method For Wound Irrigation And Debridement

#868
US20240382668A1
Human necessities

FLUIDICS CONTROL SYSTEM FOR MULTI CATHETER STACK

#869
US20240382669A1
Human necessities

APPARATUS, SYSTEM AND METHOD FOR HEATING FLUIDS

#870
US20240382670A1
Human necessities

SYRINGE INFUSION PUMP

#871
US20240382671A1
Human necessities

INFUSION DEVICE HAVING A PROCESSING DEVICE CONFIGURED TO DETERMINE A VALUE INDICATIVE OF A SENSITIVITY OF A SENSOR DEVICE

#872
US20240382672A1
Human necessities

ELECTROOSMOTIC PUMP

#873
US20240382673A1
Human necessities

INSERTION MECHANISM FOR DRUG DELIVERY DEVICE

#874 ✅ Patent 12,324,899 granted on 2025-06-10
US20240382674A1
Human necessities

INFUSION SET AND INSERTER ASSEMBLY SYSTEMS AND METHODS

#875
US20240382675A1
Human necessities

SYSTEM AND METHOD FOR DETECTING A LEAKING OCCLUDER VALVE IN A PERISTALTIC PUMP

#876
US20240382676A1
Human necessities

Method and Apparatus for Wetting Internal Fluid Path Surfaces of a Fluid Port to Increase Ultrasonic Signal Transmission

#877
US20240382677A1
Human necessities

AUTO-INJECTOR AND RELATED METHODS OF USE

#878
US20240382678A1
Human necessities

AUTO-INJECTOR AND RELATED METHODS OF USE

#879 ✅ Patent 12,246,166 granted on 2025-03-11
US20240382679A1 ⚡
Human necessities

Integrated insulin delivery system with continuous glucose sensor

#880
US20240382680A1
Human necessities

INJECTION FLUID QUANTIFICATION

#881
US20240382681A1
Human necessities

AUTO-INJECTOR AND RELATED METHODS OF USE

#882
US20240382682A1
Human necessities

Self-Administered Injection Device And Method

#883
US20240382683A1
Human necessities

DEVICE FOR ADMINISTERING A FLUID

#884
US20240382684A1
Human necessities

Syringe Assembly with In-Molded RFID Sleeve

#885
US20240382685A1
Human necessities

INJECTOR DEVICE COMPONENT SURFACE MODIFICATION

#886
US20240382686A1
Human necessities

Electronic Module, Drug Delivery Device and Method for Operating an Electronic Module

#887
US20240382687A1
Human necessities

Electronic module, drug delivery device and method for operating an electronic module

#888
US20240382688A1
Human necessities

Data Collection Device For Attachment To An Injection Device

#889
US20240382689A1
Human necessities

TUNING OF AT LEAST ONE THRESHOLD OF A SENSOR OF A DRUG DELIVERY DEVICE OR OF A DRUG DELIVERY ADD-ON DEVICE

#890
US20240382690A1
Human necessities

AWAKENING ELECTRONICS

#891
US20240382691A1
Human necessities

AUTOINJECTOR

#892
US20240382692A1
Human necessities

PREFILLED SYRINGE FORMULATION WITH NEEDLE WITH NEEDLE SHIELD CONTAINING NOVEL MODIFIED ANTIBODY

#893
US20240382693A1
Human necessities

Injection System and Method

#894
US20240382694A1
Human necessities

TRACKING SYSTEM FOR A COUPLING DEVICE

#895
US20240382695A1
Human necessities

POLYMERIC INJECTION SYSTEMS

#896
US20240382696A1
Human necessities

A VEIN VISUALISATION AID DEVICE

#897
US20240382697A1
Human necessities

BLOOD VESSEL VISUALIZATION DEVICE, BLOOD VESSEL PUNCTURE SYSTEM, AND BLOOD VESSEL VISUALIZATION SYSTEM

#898
US20240382698A1
Human necessities

BLOOD VESSEL VISUALIZATION MEMBER, BLOOD VESSEL VISUALIZATION DEVICE, BLOOD VESSEL PUNCTURE SYSTEM, AND BLOOD VESSEL VISUALIZATION SYSTEM

#899
US20240382699A1
Human necessities

DETERMINING DATA RELATED TO THE APPROACH OF END OF LIFE OF A DRUG DELIVERY DEVICE

#900
US20240382700A1
Human necessities

SPRAY HEAD AND DEVICE FOR INTRANASAL SPRAYING OF LIQUID MEDICINE